Variability in the integrity of human enteroviruses exposed to various simulated in vivo environments

Microbial Pathogenesis

Volumn 25, Issue 3, 1998, Pages 131-137

  Piirainen, Liisa ^a   Hovi, Tapani ^a   Roivainen, Merja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Enteroviruses; Environment; Host enzymes; Infectivity; Proteolytic cleavage

Indexed keywords

CAPSID PROTEIN; TRYPSIN;

ANIMAL CELL; ARTICLE; BODY FLUID; COXSACKIE VIRUS A; ECHO VIRUS; ENTEROVIRUS; HUMAN; HUMAN CELL; INTESTINE FLUID; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS INACTIVATION; VIRUS INFECTION;

ANIMALIA; COXSACKIEVIRUS; ECHOVIRUS; ENTEROVIRUS; HUMAN PARECHOVIRUS 1; MIRIDAE; POLIOVIRUS; RNA VIRUSES;

EID: 0031756803     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0221     Document Type: Article

References (20)

1. Newman JFE, Rowlands DJ, Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol 1973; 18: 171-80.
2. Fricks CE, Icenogle JP, Hogle JM. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J Virol 1985; 54: 856-9.
3. Icenogle JP, Minor PD, Ferguson M, Hogle JM. Modulation of humoral response to a 12-amino acid site on the poliovirus virion. J Virol 1986; 60: 297-301.
4. Minor PD, Ferguson M, Phillips A, Magrath DI, Huovilainen A, Hovi T. Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol 1987; 68: 1857-65.
5. Roivainen M, Hovi T. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine. J Virol 1987; 61: 3749-53.
6. Roivainen M, Hovi T. Cleavage of VP1 and modification of antigenic site 1 of type 2 poliovirus by intestinal trypsin. J Virol 1988; 62: 3536-9.
7. Roivainen M, Huovilainen A, Hovi T. Antigenic modification of polioviruses by host proteolytic enzymes. Arch Virol 1990; 111: 115-25.
8. Hogle JM, Chow M, Filman J. Three dimensional structure of poliovirus at 2.9 A resolution. Science 1985; 229: 1358-65.
9. Roivainen M, Montagnon B, Chalumeau H, Murray M, Wimmer E, Hovi T. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice. J Virol 1990; 64: 559-62.
10. Piirainen L, Airaksinen A, Hovi T, Roivainen M. Selective cleavage by trypsin of the capsid protein VP1 of type 3 poliovirus results in improved sorting of cell bound virions. Arch Virol 1996; 141: 1011-20.
11. Roivainen M, Hyypiä T, Piirainen L, Stanway G, Hovi T. RGD-dependent entry of coxsackievirus A9 to host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 1991; 65: 4735-40.
12. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
13. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1987; 76: 4350-4.
14. Roivainen M, Piirainen L, Hovi T. Efficient RGD-independent entry process of coxsackievirus A9. Arch Virol 1996; 141: 1909-19.
15. Filman DJ, Syed R, Chow M, MacAdam JA, Minor PD, Hogle JM. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 1989; 8: 1567-79.
16. McPhee F, Zell R, Reimann BY, Hofschneider PH, Kandolf R. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigenic chimeras. Virus Res 1994; 34: 139-51.
17. Chang KH, Day C, Walker J, Hyypiä T, Stanway G. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD-containing extension to the VPl protein has functional importance. J Gen Virol 1992; 73: 621-6.
18. Stanway G, Kalkkinen N, Roivainen M, et al. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 1994; 68: 8232-8.
19. Hovi T, Stenvik M, Rosenlew M. Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiol Infect 1996; 116: 91-7.
20. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 1993; 31: 1083-7.